# Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion

> **NCT02010827** · — · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** isoglycemic intravenous glucose infusion and Glucagon infusion, day C
- **BIOLOGICAL:** Oral glucose tolerance test, day A
- **BIOLOGICAL:** intravenous iv glucose infusion, day B

## Key facts

- **NCT ID:** NCT02010827
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-09
- **Final completion:** 2015-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010827, "Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02010827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*